NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 22 April 2010 The ACCORD lipid trial in patients with type 2 diabetes concluded that intensifying lipid modification therapy through combination use of fenofibrate and simvastatin (at a daily […]
Category Archives: Lipids
NPC Archive Item: Small local ‘snapshot’ study should not discourage use of low cost statins
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 22 March 2010 A study of administrative data from one PCT suggested that practices which tended to use more lower-cost statins had slightly fewer patients with a total cholesterol […]
NPC Archive Item: Statins and risk of diabetes
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 01 March 2010 This meta-analysis found statin therapy was associated with a small increase in the absolute risk of developing diabetes. However, for people in whom statin therapy is […]
NPC Archive Item: Report considers hospital prescribing of ‘NICE appraised’ and ‘low cost’ medicines.
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 30 November 2009 The NHS Information Centre has issued a report considering expenditure on medicines in hospitals in England in 2008. It includes a table focusing on medicines positively […]
NPC Archive Item: Updated information on adverse effects of statins
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 30 November 2009 The MHRA has published a public assessment report which discusses a review of some of the adverse effects of statins. The review concluded that the following […]
NPC Archive Item: Independent validation of QRISK supports its superiority over Framingham in the UK population
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 21st July 2009 This independent validation of the QRISK tool found that QRISK showed better calibration and better discrimination in predicting CV risk than the Framingham-based tool currently recommended […]
NPC Archive Item: Ezetimibe and cancer — more reassuring data
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 1st July 2009 An analysis of post-marketing adverse event reports did not find any increased risk of cancer with ezetimibe▼ compared with statins, either alone or when taken in […]
NPC Archive Item: Standard dose statins reduce the risk of CHD in patients with familial hypercholesterolaemia
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 10th June 2009 This retrospective cohort study found that statins significantly reduced the risk of coronary heart disease (CHD) in patients with familial hypercholesterolaemia (FH), even though they were […]
NPC Archive Item: Resources relating to Better Care, Better Value indicators
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 9th April 2009 The NHS Institute for Innovation and Improvement has recently released four Better Care, Better Value Indicators (BCBV) relating to prescribing. NPC includes resources which will help […]
NPC Archive Item: The polypill – interesting DOO data, but no POOs yet
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 6th April 2009 The Indian Polycap Study (TIPS), a short term, phase II study, suggests that a combination capsule which includes five active ingredients has similar effects on cardiovascular […]